Vanderbilt researchers on guanfacine for hyperadrenergic patients, Pamela Roff, B.S. posted on the topic

$ 6.50

4.5
(141)
In stock
Description

Vanderbilt researchers recently presented new data on the use of guanfacine in 47 hyperadrenergic #POTS patients. They note that 72% of patients responded well…

Pamela Roff, B.S. on LinkedIn: Vagus Nerve Dysfunction in the Post-COVID-19 Condition

Why Physicians Commit Suicide - Pamela Wible MD

Pamela Roff, B.S. - Provider Relations - South Denver Cardiology Associates

Pamela Roff, B.S. - Provider Relations - South Denver Cardiology Associates

Rishad Usmani, MD on LinkedIn: There is tension between personalized care and evidence based care…

Brian Robert Tees, MBA on LinkedIn: Transplant Genomics is taking the mission to Capitol Hill! This week, key…

Pamela Roff, B.S. on LinkedIn: Research News: Researchers in Germany recently described a group of…

Pamela Roff, B.S. on LinkedIn: Vagus Nerve Dysfunction in the Post-COVID-19 Condition

Pamela Roff, B.S. on LinkedIn: What is POTS?

Brian Robert Tees, MBA on LinkedIn: Transplant Genomics is taking the mission to Capitol Hill! This week, key…

Pamela Roff, B.S. on LinkedIn: CALLING ALL RESEARCHERS! Dysautonomia International is now accepting grant…

Vanderbilt researchers on guanfacine for hyperadrenergic patients, Pamela Roff, B.S. posted on the topic

Brian Robert Tees, MBA on LinkedIn: Transplant Genomics is taking the mission to Capitol Hill! This week, key…